Phase 1 first-in-human, single and multiple dosing study of FB301 in healthy female subjects

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517539-38-00

Acronym

FRB-002

Enrollment

Registered

2025-02-06

Start date

2025-02-13

Completion date

Unknown

Last updated

2025-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women infertility

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026